Related Experiment Video
Updated: Jul 9, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Development and evaluation of automated screening algorithms for pre-analytical errors in pharmacokinetic data: a
Minsub Shim1, Jaegu Kang1, Kyung-Sang Yu1
1Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea.
Abstract:
Pre-analytical errors such as sample mix-ups can compromise the integrity of pharmacokinetic (PK) data. We simulated vancomycin PK data and introduced two error types: intra-individual time point swap (TS) errors and inter-individual concentration swap (CS) errors. This study developed and validated two automated detection approaches-a run-test-based non-parametric method and a Mahalanobis distance-based method with leave-one-out cross-validation (LOOCV)-for identifying pre-analytical errors in PK datasets. Performance was evaluated using 12,500 simulated profiles comparing the two methods. The distance-based method demonstrated significantly higher error detection rate (79.7% vs. 59.6%, p < 0.001) and greater area under the receiver operating characteristic curve (0.856; 95% confidence interval [CI], 0.816-0.889 vs. 0.574; 95% CI, 0.541-0.610) compared to the run-test, while maintaining reasonable specificity (76.4% vs. 84.0%). For TS errors, the distance-based method achieved higher recall (80.4% vs. 71.9%) and modestly higher F1-score (0.530 vs. 0.515). For CS errors, the distance-based method demonstrated superior precision (86.1% vs. 59.8%) with comparable F1-score (0.572 vs. 0.564). Detection was robust across alternative PopPK models, a structurally different drug (theophylline), training-set contamination (with the minimum covariance determinant estimator recommended for non-curated training), missing data (with sub-vector marginal handling), and sampling-time jitter. Overall, the distance-based method with LOOCV outperformed the conventional run-test across key performance metrics and can serve as a practical quality control tool for ensuring PK data integrity in clinical pharmacology research.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Preclinical Development: Overview
